The federal program aims to get stroke patients treated faster through autonomous mechanical thrombectomy. Several organizations will share up to $175.3 million in funding to develop robots.

Digital health technologies used in studies should be validated and measure outcomes that matter to patients, the FDA said.

Stryker, Medtronic and Abbott are among the collection of medical device firms that have disclosed cyberattacks this year. Check out MedTech Dive’s roundup of coverage.

The Food and Drug Administration hailed the potential of the first-of-its-kind device to counter the U.S. phlebotomist ...

John Rogers, who has experience leading change at companies, is expected to help Baxter’s turnaround gain traction. He joins ...

The agency published a discussion paper this week as it considers the “unique risks” and potential promise of generative AI ...

As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for ...

William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” ...

Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing ...

BD called completing enrollment in the study “a significant milestone in its advanced tissue regeneration strategy and ...

The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world ...

European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.